Modulation of tumour necrosis factor-α-induced cytotoxicity by polyphenols

Phytotherapy Research

Volumn 11, Issue 4, 1997, Pages 277-280

  Habtemariam, Solomon ^a  

^a UNIVERSITY OF STRATHCLYDE   (United Kingdom)

Author keywords

Cathechols; L929 cells; Phenols; protection; TNF cytotoxicity

Indexed keywords

4 HYDROXYBENZOIC ACID; BETA RESORCYLIC ACID; CAFFEIC ACID; CATECHOL; CATECHOL DERIVATIVE; CINNAMIC ACID; DOPAMINE; FERULIC ACID; NORADRENALIN; PHENOL DERIVATIVE; PROTOCATECHUIC ACID; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VANILLIC ACID; VERATRIC ACID;

ANIMAL CELL; ARTICLE; CELL CULTURE; CELL STRAIN L 929; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; DOSE RESPONSE; IMMUNOCYTOCHEMISTRY; IN VITRO STUDY; NONHUMAN;

EID: 0030950377     PISSN: 0951418X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1099-1573(199706)11:4<277::AID-PTR90>3.0.CO;2-8     Document Type: Article

References (32)

1. Alanko, J., Riutta, A., and Vapatolo, H. (1992). Effects of catecholamines on eicosanoid synthesis with special reference to prostanoid/leukotriene ratio. Free Rad. Biol. Med. 13, 677-688.
2. Beutler, B., and Cerami, A. (1989). The biology of cachectin/TNF: a primary mediator of host response against a human tumour necrosis factor-α receptor. Annu. Rev. Immunol. 7, 625-655.
3. Bhimani, R., Troll, W., Grunberger, D., and Frenkel, K. (1993). Inhibition of oxidative stress in HeLa cells by chemoprotective agents. Cancer Res. 53, 4528-4533.
4. Burden, R. H. (1992). Iron chelating agents with clinical potential. Proc. Roy. Soc. Edin. 99B, 169-176.
5. Cho, H., Veda, M., Tamaoka, M. et al. (1991). Novel caffeic acid derivatives: extremely potent inhibitors of 12-lipoxygenase. J. Med. Chem. 34, 1503-1505.
6. Espvic, E., Brockhaus, M., Loetscher, H., Nonstand, U., and Shalaby, R. (1990). Characterization of binding and biological effects of monoclonal antibody against human tumor necrosis factor receptor. J. Exp. Med. 171, 415-426.
7. Frenkel, K., Wei, H., Bhamani, R. et al. (1993). Inhibition of human promoter-mediated processes in mouse skin and bovine lens by caffeic acid phenethyl ester. Cancer Res. 53, 1255-1261.
8. Fridovich, I. (1980). Biological effects of the superoxide radical. Biochem. Biophys. 247, 1-11.
9. Graf, E. (1992). Antioxidant potential of ferulic acid. Free Rad. Biol. Med. 13, 435-444.
10. Gumbinger, H. G., Vahlensieck, V., and Winterhoff, H. (1993). Metabolism of caffeic acids in the isolated perfused rat liver. Planta Med. 59, 491-493.
11. Kemal, C., Lovis-Flamberg, P., Krupinski-Olsen, R., and Shorter, A. L. (1987). Reduction inactivation of soyabean lipoxygenase-1 by catechols. Biochemistry 26, 1064-1072.
12. Lutz, W. K., and Schlatter, J. (1992). Chemical carcinogens and overnutrition in diet-related cancer. Carcinogensis 13, 2211-2216.
13. Mahmood, N., Moore, P. S., De-Tommasi, N., De-Simone, F., and Colman, S. (1993). Inhibition of HIV infection by caffeolquinic acid derivatives. Antiviral Chem. Chemother. 4, 235-240.
14. Manchester, K. M., Heston, W. D. W., and Donner, D. B. (1993). Tumour necrosis factor-induced cytotoxicity is accompanied by intracellular mitogenic signals in Me-180 human cervical carcinoma cells. Biochem. J. 290, 185-190.
15. Mashino, T., and Fridovich, I. (1987). Superoxide radical initiates the autooxidation of dihydroxy acetone. Arch. Biochem. Biophys. 254, 547-554.
16. Matthews, N., Neale, M. L., Jackson, S. K., and Stark, J. M. (1987). Tumour cell killing by tumour necrosis factor: inhibition by anaerobic condition, free radical scavengers and inhibitors of arachidonate metabolism. Immunology 762, 153-155.
17. McDevitt, J., Feighery, C., O'Farrelly, C., Martin, G., Weir, D. G., and Kelleher, D. (1995). Effects of tumour necrosis factor- alpha on BrdU incorporation in cultured human enterocytes. Mediators Inflamm. 4, 31-37.
18. Meister, A. (1994). Gluthathione, ascorbate and cellular protection. Cancer Res. (Supp.) 54, 1969s-1975s.
19. Nakayama, T. (1994). Suppression of hydrogen peroxide- induced cytotoxicity by polyphenols. Cancer Res. (Supp.) 54, 1991s-1993s.
20. Nawroth, P. P., and Stern, J. (1986). Modulation of endothelial cell hemostatic properties by tumor necrosis factor. J. Exp. Med. 163, 740-745.
21. Nelson, M. J. (1988). Catecholate complexes of ferric soyabean lipoxygenase 1. Biochemistry 27, 4273-4278.
22. O'Donnel, V. G., Spycher, S., and Azzi, A. (1995). Involvement of oxidants and oxidant-generating enzyme(s) in tumour- necrosis-factor-α-mediated apoptosis: role for lipoxygenase pathway but not mitochondrial respiratory chain. Biochem. J. 310, 133-141.
23. Old, L. J. (1987). Polypeptide mediator network. Nature 326, 330-331.
24. Park, Y. M. K., Anderson, R. L., Spitz, D. R., and Hahn, G. M. (1992). Hypoxia and resistance to hydrogen peroxide confer resistance in murine L929 cells. Radiat. Res. 131, 162-168.
25. Polunovsky, V. A., Wendt, C. H., Ingbar, D. H., Peterson, M. S., and Bitterman, P. B. (1994). Induction of endothelial cell apoptosis by TNFα: modulation by inhibitors of protein synthesis. Exp. Cell. Res. 214, 584-594.
26. Schaeffer, D., Jurgensmeier, J. M., and Bauer, G. (1995). Catechol interferes with TGF-beta-induced elimination of transformed cells during carcinogenesis. Int. J. Cancer 60, 520-526.
27. Shalaby, M. R., Sundan, A., Loetscher, H., Brockhaus, M., Lesslauer, W., and Espevik, T. (1990). Binding and regulation of cellular functions by monoclonal antibodies against human tumor necrosis factor receptors. J. Exp. Med. 172, 1517-1520.
28. Spriggs, D. R., Sherman, M. L., Michie, H. et al. (1988). Recombinant human tumor necrosis factor administered as a 24-hourcal intravenous infusion. A phase I and pharmacologic study. J. Nat. Cancer Inst. 80, 1039-1044.
29. Sudina, G. F., Mirzoeua, O. K., Pushkareva, M. A., Korshunova, G. A., and Sumbatyan, N. V. (1993). Caffeic acid phenethyl ester as a lipoxygenase inhibitor with antioxidant properties. FEBS Lett. 329, 21-24.
30. Toda, S., Kumura, M., and Ohinishi, M. (1991). Effects of phenolcarboxylic acids on superoxide anion and hydrogen peroxide induced lipid peroxidation. Planta Med. 57, 8-10.
31. Vagglini, M., Belli, F., Ammatuna, M. et al. (1994). Treatment of primary or relapsing limb cancer by isolation perfusion with high doses of alpha-tumour necrosis factor, gamma-interferon, and melphalan. Cancer 73, 483-492.
32. Vilcek, J., Palombella, V. J., Henriksen-Destifano, D. et al. (1986). Fibroblast growth enhancing activity of tumour necrosis factor and its relationship to other polypeptide growth factor. J. Exp. Med. 163, 632-643.